SystHERs Study
Study #ML28257
Condition / Intervention
Metastatic Breast Cancer
Purpose
An observational cohort study of treatment patterns and outcomes in patients with HER2 positive metastatic breast cancer.
Investigator
Neal A Fischbach, MD
Contact Information
For more information about this study and to inquire about eligibility, (203) 384-3611
More Information
View this trial on ClinicalTrials.gov
Eligibility
Inclusion Criteria:
- Adult patients, >/=18 years of age
- Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
- Availability of cancer-specific historical data points in the patient's medical records
